Sickle Cell Transition – The importance of sickle cell transition from pediatric to adult care

Presented by:
Leila Jerome Clay, MD, MCTS
Johns Hopkins All Children’s Hospital

Faculty Disclosure: Leila Jerome Clay, MD, MCTS has disclosed that she is a consultant for Novartis and Global Blood Therapeutics. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: All relevant financial relationships have been mitigated.

Release Date: December 8, 2021
Expiration Date: December 7, 2022

Target Audience: Primary Care Physicians, Specialty Physicians, Physician Assistants, Nurses, Pharmacists

Learning Objectives: As a result of participation in this activity, participants should be able to:

  • Discuss the importance of Transition from Pediatric to Adult Health Care.
  • Review the 6 Core Elements of GOT Transition in the population with Sickle Cell Disease.
  • Learn how to apply to 6 Core Elements from Pediatric to Adult Care.

Requirements for successful completion: Certificates are awarded upon successful completion (80% proficiency) of the post-test.

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resource(s) for further study:

  • Pathology of Sickle Cell Disease, Prithu Sundd, Mark T. Galdwin, Enrico M. Novelli. Annual Review of Pathology: Mechanisms of Disease 2019 14:1



For additional information, contact Debbie Ringdahl at 352-273-9120 or e-mail